Association between social contact frequency and negative symptoms, psychosocial functioning and quality of life in patients with schizophrenia

Psychiatry Research

Volumn 230, Issue 3, 2015, Pages 860-866

  Siegrist, Karin ^a   Millier, Aurelie ^b   Amri, Ikbal ^b   Aballéa, Samuel ^b   Toumi, Mondher ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b CREATIV CEUTICAL   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Emotional withdrawal; Negative symptoms; Schizophrenia; Social contact

Indexed keywords

ADULT; ARTICLE; DETERIORATION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL BEHAVIOR; SOCIAL COMPETENCE; SOCIAL PSYCHOLOGY; COGNITION; COHORT ANALYSIS; EUROPE; HUMAN RELATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOLOGY; REGRESSION ANALYSIS;

ADULT; COGNITION; COHORT STUDIES; EUROPE; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; REGRESSION ANALYSIS; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL BEHAVIOR;

EID: 84949503469     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.11.039     Document Type: Article

References (33)

1. Addington D., Addington J., Schissel B. A depression rating scale for schizophrenics. Schizophr. Res. 1990, 3(4):247-251.
2. APA (American Psychiatric Association) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV 1994, American Psychiatric Association, Washington, DC. 4th ed.
3. Bebbington P.E., Angermeyer M., Azorin J.M., Brugha T., Kilian R., Johnson S., Toumi M., Kornfeld A. The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study. Soc. Psychiatry Psychiatr. Epidemiol. 2005, 40(9):707-717.
4. Bell M., Milstein R., Beam-Goulet J., Lysaker P., Cicchetti D. The positive and negative syndrome scale and the brief psychiatric rating scale. Reliability, comparability, and predictive validity. J. Nerv. Ment. Dis. 1992, 180(11):723-728.
5. Berger, P., Luckmann, T., 1966. The Social Construction of Reality: A Treatise in the Sociology of Knowledge.
6. Boyer L., Baumstarck K., Guedj E., Auquier P. What's wrong with quality-of-life measures? A philosophical reflection and insights from neuroimaging. Expert Rev. Pharmacoecon. Outcomes Res. 2014, 14(6):767-769.
7. Breier A., Schreiber J.L., Dyer J., Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch. Gen. Psychiatry 1991, 48(3):239-246.
8. Brüne M., Schaub D., Juckel G., Langdon R. Social skills and behavioral problems in schizophrenia: the role of mental state attribution, neurocognition and clinical symptomatology. Psychiatry Res. 2011, 190(1):9-17.
9. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophr. Bull. 2007, 33(4):1013-1022.
10. Corcoran C.M., Kimhy D., Parrilla-Escobar M.A., Cressman V.L., Stanford A.D., Thompson J., David S.B., Crumbley A., Schobel S., Moore H., Malaspina D. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol. Med. 2011, 41(2):251-261.
11. Csukly G., Stefanics G., Komlosi S., Czigler I., Czobor P. Emotion-related visual mismatch responses in schizophrenia: impairments and correlations with emotion recognition. PLoS One 2013, 8(10):e75444.
12. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 1976, 33(6):766-771.
13. Fenton W.S., McGlashan T.H. Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Arch. Gen. Psychiatry 1991, 48(11):978-986.
14. Fleury M.J., Grenier G., Bamvita J.M., Tremblay J., Schmitz N., Caron J. Predictors of quality of life in a longitudinal study of users with severe mental disorders. Health Qual. Life Outcomes 2013, 11(1):92.
15. Gaite L., Vazquez-Barquero J.L., Herran A., Thornicroft G., Becker T., Sierra-Biddle D., Ruggeri M., Schene A., Knapp M., Vazquez-Bourgon J. Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study. Compr. Psychiatry 2005, 46(6):440-446.
16. Giacco D., McCabe R., Kallert T., Hansson L., Fiorillo A., Priebe S. Friends and symptom dimensions in patients with psychosis: a pooled analysis. PLoS One 2012, 7(11):e50119.
17. Hansen C.F., Torgalsboen A.K., Melle I., Bell M.D. Passive/apathetic social withdrawal and active social avoidance in schizophrenia: difference in underlying psychological processes. J. Nerv. Ment. Dis. 2009, 197(4):274-277.
18. Hunter R., Cameron R., Norrie J. Using patient-reported outcomes in schizophrenia: the Scottish Schizophrenia Outcomes Study. Psychiatr. Serv. 2009, 60(2):240-245.
19. Jelastopulu E., Giourou E., Merekoulias G., Mestousi A., Moratis E., Alexopoulos E.C. Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia. BMC Psychiatry 2014, 14:197.
20. Katschnig H. Schizophrenia and quality of life. Acta Psychiatr. Scand. Suppl. 2000, 407:33-37.
21. Kay S.R., Opler L.A., Lindenmayer J.P. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br. J. Psychiatry Suppl. 1989, 7:59-67.
22. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32(2):214-219.
23. Kring A.M., Gur R.E., Blanchard J.J., Horan W.P., Reise S.P. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am. J. Psychiatry 2013, 170(2):165-172.
24. Lehman A.F. The well-being of chronic mental patients: Assessing their quality of life. Arch Gen Psychiatry 1983, 40:369-373.
25. Lehman A.F. The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval. Program Plann. 1983, 6(2):143-151.
26. Lehman A.F., Postrado L.T., Rachuba L.T. Convergent validation of quality of life assessments for persons with severe mental illnesses. Qual. Life Res. 1993, 2(5):327-333.
27. Norman R.M., Malla A.K., McLean T., Voruganti L.P., Cortese L., McIntosh E., Cheng S., Rickwood A. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr. Scand. 2000, 102(4):303-309.
28. Puig O., Penades R., Gasto C., Catalan R., Torres A., Salamero M. Verbal memory, negative symptomatology and prediction of psychosocial functioning in schizophrenia. Psychiatry Res. 2008, 158(1):11-17.
29. Rocca P., Montemagni C., Castagna F., Giugiario M., Scalese M., Bogetto F. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(2):373-379.
30. Schmidt, L.J., Garratt, A.M., Fitzpatrick, R., 2000. Instruments for Mental Health: A Review Report from the Patient-Reported Health Instruments Group (Formerly the Patient-Assessed Health Outcomes Programme) to the Department of Health.
31. Smith T.E., Hull J.W., Huppert J.D., Silverstein S.M. Recovery from psychosis in schizophrenia and schizoaffective disorder: symptoms and neurocognitive rate-limiters for the development of social behavior skills. Schizophr. Res. 2002, 55(3):229-237.
32. Weinberg D., Shahar G., Davidson L., McGlashan T.H., Fennig S. Longitudinal associations between negative symptoms and social functioning in schizophrenia: the moderating role of employment status and setting. Psychiatry 2009, 72(4):370-381.
33. WMA Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects 2008, World Medical Association, General Assembly, Seoul.